核因子红色素2相关的因子2通过抑制铁亡,缓解肺内皮细胞损伤
Xiaotong Yin1, Chongbing Yan1, Bowen Weng1
1Department of Neonatology, Shanghai Children's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Translational pediatrics
|December 9, 2024
概括
铁,一种与活性氧物种 (ROS) 相关的细胞死亡形式,有助于高氧性肺损伤 (HLI). 向核因子红色素2相关因子2 (Nrf2) 可能通过抑制铁亡来保护HLI.
科学领域:
- 细胞和分子医学 细胞和分子医学
- 肺部研究 肺部研究
- 毒理学 毒理学 毒理学
背景情况:
- 改善早产婴儿存活率增加了肺部疾病的发病率,这是由于过氧诱导的活性氧物种 (ROS).
- 过氧性肺损伤 (HLI) 涉及过量的ROS产生和炎症,目前没有有效的治疗方法.
- 铁亡,一种与ROS相关的细胞死亡,与HLI有关,其通过核因子红色素2相关因子2 (Nrf2) 的调节呈现出治疗点.
研究的目的:
- 为了研究铁死在高氧性肺损伤 (HLI) 中的作用.
- 阐明核因素红色素2相关因子2 (Nrf2) 在HLI和铁死中的调节功能.
主要方法:
- 人类肺微血管内皮细胞 (HPMEC) 暴露于高氧化.
- 评估了细胞活力,ROS水平和铁亡标志物 (GPX4,Nrf2).
- 线粒体形态通过传输电子显微镜 (TEM) 检查.
主要成果:
- 过氧症降低了HPMEC的活力,并增加了ROS水平.
- 观察到具有铁亡的特征的线粒体变化.
- 铁灭抑制保护细胞,而Nrf2抑制则逆转了这些保护作用.
结论:
- 铁致死有助于高氧性肺损伤 (HLI) 的致病.
- 核因子红色素2相关因子2 (Nrf2) 通过减轻HLI中的铁亡起着保护作用.
更多相关视频
相关概念视频
Necrosis
4.3K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.3K
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
Electron Transport Chain: Complex I and II
11.5K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
11.5K
NF-κB-dependent Signaling Pathway
7.2K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.2K
Erythropoiesis
4.1K
Red blood cells (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia,...
4.1K
Role of Hematopoietic Growth Factors
1.2K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.2K


